Stock Price Movement and Market Context
On 13 July 2026, Sampre Nutritions Ltd recorded its lowest price in the past year at Rs.5.55, representing a day change of -1.54%. This decline extended an eight-day losing streak during which the stock has fallen by 28.21%. The stock’s performance notably lagged behind the FMCG sector, underperforming by 0.85% on the day.
The broader market context saw the Sensex open lower at 76,963.35, down 606.04 points (-0.78%), and trading at 77,170.01 (-0.51%) during the same session. While the Sensex remains above its 50-day moving average, the 50DMA itself is positioned below the 200DMA, signalling some underlying market caution.
Technical Indicators Highlight Bearish Momentum
Technical analysis of Sampre Nutritions Ltd reveals a predominantly bearish outlook. The stock is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating sustained downward momentum. Weekly and monthly MACD and Bollinger Bands readings are bearish, while the Dow Theory also suggests mild bearishness on both weekly and monthly timeframes. The KST indicator presents a mixed signal with weekly bearishness but monthly bullishness, though this has not translated into price strength.
Long-Term Performance and Valuation Metrics
Over the past year, Sampre Nutritions Ltd has delivered a negative return of 43.89%, significantly underperforming the Sensex’s decline of 6.46% over the same period. The stock’s 52-week high was Rs.42.33, underscoring the steep depreciation in value.
The company is classified as a micro-cap with a Mojo Score of 37.0 and a current Mojo Grade of Sell, which was downgraded from Strong Sell on 1 June 2026. This reflects a reassessment of the company’s fundamentals and market outlook.
Financial Strength and Profitability Concerns
Sampre Nutritions Ltd’s long-term fundamental strength remains weak. The average Return on Capital Employed (ROCE) stands at a modest 1.28%, indicating limited efficiency in generating returns from capital investments. Operating profit growth over the last five years has averaged 18.30% annually, which, while positive, has not translated into robust market performance.
The company’s ability to service debt is also constrained, with an average EBIT to Interest ratio of 0.47, signalling potential challenges in covering interest expenses from operating earnings. This ratio is below typical comfort levels for financial stability.
Comparative Performance Against Benchmarks
In addition to the one-year underperformance, Sampre Nutritions Ltd has lagged behind the BSE500 index over the last three years, one year, and three months. This consistent underperformance highlights structural issues affecting the company’s market valuation and investor confidence.
Recent Financial Results Show Mixed Signals
Despite the stock’s decline, the company reported positive financial results in the latest quarter ending March 2026. Net profit surged by 117.74%, and the company has declared positive results for four consecutive quarters. Net sales for the latest six months reached Rs.22.49 crores, growing at a rate of 68.46%, while PAT for the same period was Rs.1.97 crores, reflecting higher profitability.
The Debtors Turnover Ratio for the half-year stood at 3.27 times, the highest recorded, indicating improved efficiency in receivables management.
Valuation and Shareholding Structure
From a valuation perspective, Sampre Nutritions Ltd presents a very attractive profile with a ROCE of 2.6 and an enterprise value to capital employed ratio of 0.6. The stock is trading at a discount relative to its peers’ historical valuations. Over the past year, while the stock price has declined by 43.89%, profits have increased by 155.8%, resulting in a low PEG ratio of 0.1, which may indicate undervaluation based on earnings growth.
The majority of the company’s shares are held by non-institutional investors, which may influence liquidity and trading dynamics.
Summary of Technical and Market Ratings
The Mojo Grade of Sell, assigned by MarketsMOJO, reflects the current assessment of Sampre Nutritions Ltd’s financial and market position. This grade was downgraded from Strong Sell on 1 June 2026, signalling a slight improvement but still indicating caution. The micro-cap status and low Mojo Score of 37.0 further underscore the stock’s risk profile.
Technical indicators predominantly signal bearish trends, with moving averages and momentum oscillators aligned with the recent price declines.
Conclusion
Sampre Nutritions Ltd’s fall to a 52-week low of Rs.5.55 on 13 July 2026 marks a continuation of a challenging period for the stock. Despite some positive financial results and improved profitability metrics, the stock’s long-term performance, valuation concerns, and technical indicators reflect ongoing pressures. The company’s weak capital efficiency and debt servicing capacity remain areas of concern amid a broader market environment that has also shown signs of caution.
